BSN: Orchid's Amlodipine Besylate tablets get US approval

What's My Rank?
      What's My Popularity Score?
      In My Orgs?
      In My Specialities?
      In My Geography?
      In My Age?

My Mentors, Collaborators,
Associates, Peers, Buddies

Keep Me Up To Date
Specialty, Keyword,
Geography

People Making News

Latest Research From
Meetings

Recent Postings

People of Consequence (40213)

1. Richard M. Satava
University of Washington
2. Adam P Dicker
Thomas Jefferson University
3. Lena Specht
Copenhagen University
4. Richard G. Pestell
Kimmel Cancer Center
5. Warren M. Jackman
University of Oklahoma

Orgs of Consequence (10422)

1. University of California
2. Harvard University
3. Mayo Clinic
4. National Institutes of Health, Chemical Genomics Centre
5. M. D. Anderson Cancer Center

Terms of Consequence

1. Cells
2. Cancer
3. Genetics
4. Molecular
5. Proteins

Orchid's Amlodipine Besylate tablets get US approval

Friday, July 3

India-based pharmaceutical company, Orchid Chemicals and Pharmaceuticals has recieved approval from the US Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate tablets.

http://www.biospectrumasia.com/content/030709IND9874.asp

Comments

BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.

Orchid's Amlodipine Besylate tablets get US approval

Comments

Add Comment